summary
Introduced
12/09/2025
12/09/2025
In Committee
02/10/2026
02/10/2026
Crossed Over
01/28/2026
01/28/2026
Passed
03/10/2026
03/10/2026
Dead
Signed/Enacted/Adopted
03/10/2026
03/10/2026
Introduced Session
2026 Regular Session
Bill Summary
Syringe exchange program. Prohibits a qualified entity that operates a syringe exchange program (program) from establishing or operating a fixed site for the distribution or exchange of a syringe or needle within 1,000 feet of specified facilities. Creates an exception. Allows the Indiana department of health to deny, suspend, or revoke a qualified entity's annual registration for a violation. Amends the duties of a qualified entity that operates a program. Establishes requirements for program participation. Prohibits a qualified entity that operates a program from providing chemical reagents or precursors. Requires the state health commissioner to investigate any complaint regarding a qualified entity's noncompliance with the qualified entity's duties concerning the operation of a program. Permits the state health commissioner to suspend or terminate the approval of a qualified entity for noncompliance. Extends the expiration of the program to July 1, 2031.
AI Summary
This bill modifies existing Indiana law regarding syringe exchange programs, which are operated by "qualified entities" to provide sterile syringes and needles in exchange for used ones, often as part of a public health initiative to prevent the spread of diseases. Key provisions include prohibiting these programs from setting up fixed distribution or exchange sites within 1,000 feet of public schools, nonpublic schools, licensed child care centers, or buildings primarily used for religious worship, unless the operator of that facility gives written approval. The bill also clarifies that programs can still distribute overdose intervention drugs, provide referrals and education, and accept used syringes for safe disposal at these sites. It amends the requirements for qualified entities by changing the exchange policy to one sterile syringe and needle for each used one, and mandates that they maintain data on drug treatment referrals and their effectiveness. Furthermore, to participate in a program, individuals must now present valid identification and be residents of specific regions or contiguous counties to Marion County. The bill also prohibits programs from providing chemical reagents or precursors, which are substances used in the manufacturing of illegal drugs. The state health commissioner is empowered to investigate complaints of noncompliance and can suspend or terminate a program's approval, in addition to the existing authority of local bodies. Finally, the expiration date for the entire syringe exchange program chapter is extended from July 1, 2026, to July 1, 2031.
Committee Categories
Health and Social Services
Sponsors (13)
Ed Charbonneau (R)*,
Brett Clark (R)*,
Michael Crider (R)*,
Mike Bohacek (R),
Ed Clere (R),
Victoria Garcia Wilburn (D),
La Keisha Jackson (D),
Ethan Lawson (R),
Rodney Pol (D),
Lonnie Randolph (D),
Kyle Walker (R),
Shelli Yoder (D),
Alex Zimmerman (R),
Last Action
Public Law 144 (on 03/10/2026)
Official Document
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
Loading...